Chiome Bioscience Inc. vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $46 M for Chiome Bioscience Inc., 1959 times as much (market caps of Mar 8, 2026 for Chiome Bioscience Inc. and Oct 30, 2026 for Moderna, Inc.). Chiome Bioscience Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Chiome Bioscience Inc. 4583.T | Moderna, Inc. MRNA · #275 in the world |
|---|---|---|
| Profile | ||
| Country | 🇯🇵 Japan | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2010 |
| Size | ||
| Market cap | $46 M* | $90.1 B |
| Revenue | — | $1.9 B |
| Net income | — | $-2.8 B |
| Employees | — | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | — | 55.4% |
| Operating margin | — | -158.1% |
| Net margin | — | -145.2% |
| Return on equity | — | -28.9% |
| Growth | ||
| Revenue growth | — | -39.9% |
| Revenue growth, 3 years a year | — | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Cash | ||
| Free cash flow margin | — | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Mar 2026 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Chiome Bioscience Inc. or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $46 M for Chiome Bioscience Inc., 1959 times as much (market caps of Mar 8, 2026 for Chiome Bioscience Inc. and Oct 30, 2026 for Moderna, Inc.). Chiome Bioscience Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
More about Chiome Bioscience Inc.
More about Moderna, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.